Provided By PR Newswire
Last update: Aug 7, 2025
SAN FRANCISCO, Aug. 7, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2025.
Read more at prnewswire.com60.35
+1.71 (+2.92%)
Find more stocks in the Stock Screener


